Clinical trial
A Pivotal Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
NCT04112381 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 30, 2020
- Completion date
- June 30, 2026
- Enrollment
- 51 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.